Cargando…

ESG performance in the time of COVID-19 pandemic: cross-country evidence

The purpose of this paper is to compare the performance of environmental, social, and governance (ESG) in developing and developed countries prior to and during the COVID-19 pandemic; the study also seeks to reveal the impact of the COVID-19 on the performance of ESG during the pandemic period. Base...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Amosh, Hamzeh, Khatib, Saleh F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812744/
https://www.ncbi.nlm.nih.gov/pubmed/36600157
http://dx.doi.org/10.1007/s11356-022-25050-w
_version_ 1784863796967243776
author Al Amosh, Hamzeh
Khatib, Saleh F. A.
author_facet Al Amosh, Hamzeh
Khatib, Saleh F. A.
author_sort Al Amosh, Hamzeh
collection PubMed
description The purpose of this paper is to compare the performance of environmental, social, and governance (ESG) in developing and developed countries prior to and during the COVID-19 pandemic; the study also seeks to reveal the impact of the COVID-19 on the performance of ESG during the pandemic period. Based on a large international panel dataset of 12,325 company-year observations covering 2016–2021, panel regression analysis examined the study hypotheses and achieved the study objectives. The findings indicate that companies have taken precautions against the threats of the COVID-19 pandemic by ensuring compliance with ESG performance to prove their ethical behavior during a crisis. Our findings call into question the notion that companies in developed countries outperform companies in developing countries in terms of ESG performance. As a result, companies in emerging markets outperform companies in developed markets regarding environmental performance, while developed markets focus on social performance. Besides, the ESG performance is positively and significantly affected by the COVID-19, which indicates that during crises, it is important for companies to comply with ethical behavior and the most acceptable in societies. Also, the pandemic has a positive impact on both environmental and social performance, while it has a negative impact on governance performance alone. A considerable body of the literature has addressed the effect of the COVID-19 pandemic on various aspects of a company’s financial and non-financial practices. However, limited effort was given to ESG performance. The current study fills this gap by evaluating the direct effect of the COVID-19 crisis on the ESG performance in developing and developed countries. It also provides insight into the ESG performance and corporate behavior and obligations.
format Online
Article
Text
id pubmed-9812744
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98127442023-01-05 ESG performance in the time of COVID-19 pandemic: cross-country evidence Al Amosh, Hamzeh Khatib, Saleh F. A. Environ Sci Pollut Res Int Research Article The purpose of this paper is to compare the performance of environmental, social, and governance (ESG) in developing and developed countries prior to and during the COVID-19 pandemic; the study also seeks to reveal the impact of the COVID-19 on the performance of ESG during the pandemic period. Based on a large international panel dataset of 12,325 company-year observations covering 2016–2021, panel regression analysis examined the study hypotheses and achieved the study objectives. The findings indicate that companies have taken precautions against the threats of the COVID-19 pandemic by ensuring compliance with ESG performance to prove their ethical behavior during a crisis. Our findings call into question the notion that companies in developed countries outperform companies in developing countries in terms of ESG performance. As a result, companies in emerging markets outperform companies in developed markets regarding environmental performance, while developed markets focus on social performance. Besides, the ESG performance is positively and significantly affected by the COVID-19, which indicates that during crises, it is important for companies to comply with ethical behavior and the most acceptable in societies. Also, the pandemic has a positive impact on both environmental and social performance, while it has a negative impact on governance performance alone. A considerable body of the literature has addressed the effect of the COVID-19 pandemic on various aspects of a company’s financial and non-financial practices. However, limited effort was given to ESG performance. The current study fills this gap by evaluating the direct effect of the COVID-19 crisis on the ESG performance in developing and developed countries. It also provides insight into the ESG performance and corporate behavior and obligations. Springer Berlin Heidelberg 2023-01-05 2023 /pmc/articles/PMC9812744/ /pubmed/36600157 http://dx.doi.org/10.1007/s11356-022-25050-w Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Article
Al Amosh, Hamzeh
Khatib, Saleh F. A.
ESG performance in the time of COVID-19 pandemic: cross-country evidence
title ESG performance in the time of COVID-19 pandemic: cross-country evidence
title_full ESG performance in the time of COVID-19 pandemic: cross-country evidence
title_fullStr ESG performance in the time of COVID-19 pandemic: cross-country evidence
title_full_unstemmed ESG performance in the time of COVID-19 pandemic: cross-country evidence
title_short ESG performance in the time of COVID-19 pandemic: cross-country evidence
title_sort esg performance in the time of covid-19 pandemic: cross-country evidence
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812744/
https://www.ncbi.nlm.nih.gov/pubmed/36600157
http://dx.doi.org/10.1007/s11356-022-25050-w
work_keys_str_mv AT alamoshhamzeh esgperformanceinthetimeofcovid19pandemiccrosscountryevidence
AT khatibsalehfa esgperformanceinthetimeofcovid19pandemiccrosscountryevidence